HIPRALONA ENRO-I

Enrofloxacin, in injectable solution

COMPOSITION PER ML:

Enro­oxacin 50 mg

Enro­oxacin is a third generation ­uoroquinolone which has been developed to be used only in veterinary medicine. It acts by inhibiting the bacterial DNA-gyrase and is effective against a broad range of microorganisms. The minimal inhibitory concentration of enro­oxacin against the microorganisms most frequently detected in veterinary medicine (Escherichia coli, Salmonella, Pasteurella, Staphylococcus, Streptococcus and Mycoplasma) is very low. As a result of this characteristic and of the particular pharmacokinetics of this product, blood concentrations are rapidly achieved.

INDICATIONS:

Cows, Calves, Sheep and Goats: Pasteurellosis, Colibacillosis and Salmonellosis.

INTERACTIONS:

Do not administer together with bacteriostatic antibiotics (macrolides, tetracyclines).

Do not administer together with substances containing magnesium or aluminium, which can diminish the absorption of enro­oxacin.

CONTRAINDICATIONS:

- Renal and hepatic insuf‑ciency.

- Animals in a growth phase.

- Infections produced by microorganisms resistant to quinolones.

SIDE-EFFECTS:

Local lesions may occur at the injection site.

ADMINISTRATION ROUTE:

Intramuscular.

DOSAGE:

Cows, Calves, Sheep and Goats: 0.5 ml/10 b.w./day, for 3 days, equivalent to 2.5 mg of enro­oxacin/kg b.w.

OVERDOSE:

Overdosage may produce nervous stimulation. In such a case, discontinue treatment and this symptom will disappear.

WITHDRAWAL PERIOD:

Meat: 12 days.

SPECIAL PRECAUTIONS:

- Enro­oxacin should only be used in severe cases, once the bacteriological diagnosis has been performed and when resistances to other antibiotics have appeared.

- Do not store above 25 ºC. Protect from light.

- Keep out of the reach of children.

PRESENTATION:

Bottle of 100 ml.